Cargando…

The all-E. coliTXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform

The new generation of cell-free gene expression systems enables the prototyping and engineering of biological systems in vitro over a remarkable scope of applications and physical scales. As the utilization of DNA-directed in vitro protein synthesis expands in scope, developing more powerful cell-fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Garenne, David, Thompson, Seth, Brisson, Amaury, Khakimzhan, Aset, Noireaux, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546610/
https://www.ncbi.nlm.nih.gov/pubmed/34712841
http://dx.doi.org/10.1093/synbio/ysab017
_version_ 1784590221941145600
author Garenne, David
Thompson, Seth
Brisson, Amaury
Khakimzhan, Aset
Noireaux, Vincent
author_facet Garenne, David
Thompson, Seth
Brisson, Amaury
Khakimzhan, Aset
Noireaux, Vincent
author_sort Garenne, David
collection PubMed
description The new generation of cell-free gene expression systems enables the prototyping and engineering of biological systems in vitro over a remarkable scope of applications and physical scales. As the utilization of DNA-directed in vitro protein synthesis expands in scope, developing more powerful cell-free transcription–translation (TXTL) platforms remains a major goal to either execute larger DNA programs or improve cell-free biomanufacturing capabilities. In this work, we report the capabilities of the all-E. coli TXTL toolbox 3.0, a multipurpose cell-free expression system specifically developed for synthetic biology. In non-fed batch-mode reactions, the synthesis of the fluorescent reporter protein eGFP (enhanced green fluorescent protein) reaches 4 mg/ml. In synthetic cells, consisting of liposomes loaded with a TXTL reaction, eGFP is produced at concentrations of >8 mg/ml when the chemical building blocks feeding the reaction diffuse through membrane channels to facilitate exchanges with the outer solution. The bacteriophage T7, encoded by a genome of 40 kb and ∼60 genes, is produced at a concentration of 10(13) PFU/ml (plaque forming unit/ml). This TXTL system extends the current cell-free expression capabilities by offering unique strength and properties, for testing regulatory elements and circuits, biomanufacturing biologics or building synthetic cells.
format Online
Article
Text
id pubmed-8546610
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-85466102021-10-27 The all-E. coliTXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform Garenne, David Thompson, Seth Brisson, Amaury Khakimzhan, Aset Noireaux, Vincent Synth Biol (Oxf) Research Article The new generation of cell-free gene expression systems enables the prototyping and engineering of biological systems in vitro over a remarkable scope of applications and physical scales. As the utilization of DNA-directed in vitro protein synthesis expands in scope, developing more powerful cell-free transcription–translation (TXTL) platforms remains a major goal to either execute larger DNA programs or improve cell-free biomanufacturing capabilities. In this work, we report the capabilities of the all-E. coli TXTL toolbox 3.0, a multipurpose cell-free expression system specifically developed for synthetic biology. In non-fed batch-mode reactions, the synthesis of the fluorescent reporter protein eGFP (enhanced green fluorescent protein) reaches 4 mg/ml. In synthetic cells, consisting of liposomes loaded with a TXTL reaction, eGFP is produced at concentrations of >8 mg/ml when the chemical building blocks feeding the reaction diffuse through membrane channels to facilitate exchanges with the outer solution. The bacteriophage T7, encoded by a genome of 40 kb and ∼60 genes, is produced at a concentration of 10(13) PFU/ml (plaque forming unit/ml). This TXTL system extends the current cell-free expression capabilities by offering unique strength and properties, for testing regulatory elements and circuits, biomanufacturing biologics or building synthetic cells. Oxford University Press 2021-08-04 /pmc/articles/PMC8546610/ /pubmed/34712841 http://dx.doi.org/10.1093/synbio/ysab017 Text en © The Author(s) 2021. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Article
Garenne, David
Thompson, Seth
Brisson, Amaury
Khakimzhan, Aset
Noireaux, Vincent
The all-E. coliTXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform
title The all-E. coliTXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform
title_full The all-E. coliTXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform
title_fullStr The all-E. coliTXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform
title_full_unstemmed The all-E. coliTXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform
title_short The all-E. coliTXTL toolbox 3.0: new capabilities of a cell-free synthetic biology platform
title_sort all-e. colitxtl toolbox 3.0: new capabilities of a cell-free synthetic biology platform
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546610/
https://www.ncbi.nlm.nih.gov/pubmed/34712841
http://dx.doi.org/10.1093/synbio/ysab017
work_keys_str_mv AT garennedavid theallecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform
AT thompsonseth theallecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform
AT brissonamaury theallecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform
AT khakimzhanaset theallecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform
AT noireauxvincent theallecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform
AT garennedavid allecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform
AT thompsonseth allecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform
AT brissonamaury allecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform
AT khakimzhanaset allecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform
AT noireauxvincent allecolitxtltoolbox30newcapabilitiesofacellfreesyntheticbiologyplatform